Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Biotricity Stock (NASDAQ: BTCY) stock price, news, charts, stock research, profile.
Open2.130 | Close2.110 |
Vol / Avg.3.967K / 65.934K | Mkt Cap18.074M |
Day Range2.080 - 2.180 | 52 Wk Range1.900 - 9.120 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.040 | 0.3700 | ||||
REV | 3.100M | 3.021M | -79.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-05 | HC Wainwright & Co. | Kevin Dede | Reiterates | BuyBuy | Raises | 2.00 | 4.00 |
2023-02-15 | HC Wainwright & Co. | Kevin Dede | Reiterates | Buy | Maintains | - | 2.00 |
2022-07-15 | Maxim Group | Allen Klee | Downgrades | BuyHold | - | - | - |
2022-07-15 | HC Wainwright & Co. | Kevin Dede | Maintains | Buy | Lowers | 6.00 | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BTCY | Biotricity | -1.4% | 18.1M |
OPRX | OptimizeRx | 2.12% | 128.1M |
AHI | Advanced Health | -7.99% | 18.6M |
MEDS | Trxade Health | 6.34% | 8.8M |
BFRG | Bullfrog AI Hldgs | 3.65% | 20.8M |
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
Other companies in Biotricity’s space includes: OptimizeRx (NASDAQ:OPRX), Advanced Health (NASDAQ:AHI), Trxade Health (NASDAQ:MEDS), Bullfrog AI Hldgs (NASDAQ:BFRG) and CareCloud (NASDAQ:CCLD).
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on Wednesday, July 5, 2023. The analyst firm set a price target for 4.00 expecting BTCY to rise to within 12 months (a possible 89.57% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $2.11 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for Biotricity.
Biotricity’s Q2 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.